Mylan's Sweetened $33B Perrigo Bid Gets Spurned
Mylan Pharmaceuticals Inc raised its bid for Perrigo Co. PLC to $32.6 billion on Friday to only again get rejected by the Irish maker of over-the-counter drugs and health products, while...To view the full article, register now.
Already a subscriber? Click here to view full article